Advertisement
Coronavirus antibody test results may not be accurate enough to help guide decisions about whether to allow large groups of people to gather at work

CDC: Coronavirus Antibody Tests Still Not Accurate Enough

0
Too little is known about what the presence of antibodies means in terms of future immunity
Adults with severe chronic disease or with fair or poor general health have a higher prevalence of edentulism and severe tooth loss

Tooth Loss More Prevalent in Adults With Chronic Disease

0
Prevalence of edentulism, severe tooth loss ≥50 percent higher for adults with RA, asthma, diabetes
Lung cancer patients who are given the opportunity to be informed of their diagnosis have a longer median survival time

Early Informed Lung Cancer Patients Have Greater Survival Rates

0
Predicted survival time for patients who were unaware of their diagnosis was poor
In 2018

Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services

0
Wide regional variation seen for availability of telehealth outpatient visits, tele-ICU services
African-American patients have an increased likelihood of hospitalization for COVID-19

African-Americans More Likely to Be Hospitalized With COVID-19

0
Odds of hospitalization increased 2.7-fold versus non-Hispanic whites after adjustment for age, sex, comorbidity
Right ventricular dilation is associated with in-hospital mortality among patients hospitalized with COVID-19

Right Ventricular Dilation Linked to Mortality in COVID-19

0
Right ventricular enlargement significantly linked to in-hospital mortality in multivariable analysis
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe

Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

0
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
For patients with COVID-19 requiring hospitalization

Hydroxychloroquine Plus Macrolides No Benefit in COVID-19

0
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

0
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

0
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily